A detailed history of Beaconlight Capital, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Beaconlight Capital, LLC holds 74,815 shares of NTRA stock, worth $12.6 Million. This represents 4.22% of its overall portfolio holdings.

Number of Shares
74,815
Previous 92,311 18.95%
Holding current value
$12.6 Million
Previous $10 Million 4.88%
% of portfolio
4.22%
Previous 4.61%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$97.75 - $129.67 $1.71 Million - $2.27 Million
-17,496 Reduced 18.95%
74,815 $9.51 Million
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $1.49 Million - $1.96 Million
17,424 Added 23.27%
92,311 $10 Million
Q1 2024

May 14, 2024

SELL
$59.21 - $92.9 $7.53 Million - $11.8 Million
-127,114 Reduced 62.93%
74,887 $6.85 Million
Q4 2023

Feb 13, 2024

SELL
$37.55 - $62.64 $2.17 Million - $3.62 Million
-57,864 Reduced 22.27%
202,001 $12.7 Million
Q3 2023

Nov 14, 2023

BUY
$43.4 - $62.52 $2.68 Million - $3.86 Million
61,708 Added 31.14%
259,865 $11.5 Million
Q2 2023

Aug 11, 2023

SELL
$47.08 - $55.16 $301,782 - $353,575
-6,410 Reduced 3.13%
198,157 $9.64 Million
Q1 2023

May 12, 2023

BUY
$36.57 - $58.29 $2.66 Million - $4.24 Million
72,678 Added 55.11%
204,567 $11.4 Million
Q4 2022

Feb 14, 2023

BUY
$34.17 - $47.91 $2.63 Million - $3.69 Million
76,996 Added 140.27%
131,889 $5.3 Million
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $2.03 Million - $3.11 Million
54,893 New
54,893 $2.41 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Beaconlight Capital, LLC Portfolio

Follow Beaconlight Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaconlight Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaconlight Capital, LLC with notifications on news.